CRISPR Therapeutics AG Lease Agreements
7 Contracts & Agreements
- Lease Commencement Date Agreement, dated May 1, 2022, by and between CRISPR Therapeutics AG and 105 W First Street Owner, L.L.C (Filed With SEC on August 8, 2022)
- Second Amendment to Lease dated April __, 2021, by and between CRISPR Therapeutics, Inc. and 33 NYA OWNER (DE) LLC, as successor in interest to CRP/KING 33 NY AVE. OWNER, L.L.C (Filed With SEC on July 29, 2021)
- First Amendment to Lease dated December 2, 2020, by and between CRISPR Therapeutics, Inc. and CRP/KING 33 NY AVE. OWNER, L.L.C (Filed With SEC on April 27, 2021)
- Lease, dated May 5, 2020, by and between CRISPR Therapeutics, Inc. and CRP/KING 33 NY AVE. OWNER, L.L.C (Filed With SEC on April 27, 2021)
- Lease, dated July 24, 2020, by and between the Registrant and 105 W First Street Owner, L.L.C (Filed With SEC on July 27, 2020)
- Assignment of Sublease and Sub-Sublease, dated December 13, 2019, between Casebia Therapeutics LLC and CRISPR Therapeutics, Inc (Filed With SEC on February 12, 2020)
- CONSENT TO SUBLEASE (Filed With SEC on September 9, 2016)
